logo
Select company
Select metric
19.84%Operating Cash Flow Margin
VS
Market
70
Sector
86
Industry
77
History
70
$ 9.16Close
$ 4.26 - $ 11.97 52-Week Range
Ticker Information

Ticker

EBS

Company Name

EMERGENT BIOSOLUTIONS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSE

EMERGENT BIOSOLUTIONS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EBS - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ 169M19.84%$ 851.6M
3/31/2025$ 110.1M11.4%$ 965.4M
12/31/2024$ 58.7M5.62%$ 1.04B
9/30/2024$ 170.7M15.17%$ 1.13B
6/30/2024$ 77M6.99%$ 1.1B
3/31/2024$ -84.9M-7.16%$ 1.19B
12/31/2023$ -206.3M-19.66%$ 1.05B
9/30/2023$ -145.6M-13.19%$ 1.1B
6/30/2023$ -279.6M-26.04%$ 1.07B
3/31/2023$ -180.8M-18.48%$ 978.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EMERGENT BIOSOLUTIONS INC's latest trailing twelve months (TTM) OCF % stands at 30.99%.
  • Over the past 5 years, EMERGENT BIOSOLUTIONS INC's average OCF % has been 8.2%.
  • The median OCF % for EMERGENT BIOSOLUTIONS INC during this period was 13.85%
  • EMERGENT BIOSOLUTIONS INC reached its highest OCF % over the past 5 years at 34.46%.
  • The lowest OCF % recorded by EMERGENT BIOSOLUTIONS INC in the same timeframe -26.04%

EMERGENT BIOSOLUTIONS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
OFIX : ORTHOFIX MEDICAL INC 3.54%ESPR : ESPERION THERAPEUTICS INC -46.37%ORGO : ORGANOGENESIS HOLDINGS INC -7.72%MYGN : MYRIAD GENETICS INC -2.71%AVNS : AVANOS MEDICAL INC 16.38%SIGA : SIGA TECHNOLOGIES INC 66.28%VREX : VAREX IMAGING CORP 7.27%EHAB : ENHABIT INC 5.09%INNV : INNOVAGE HOLDING CORP 3.85%EOLS : EVOLUS INC -14.87%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for EMERGENT BIOSOLUTIONS INC is calculated as follows: CF - Operations [ $ 413M ] / Revenues [ $ 1.33B ]
(=) OCF % [ 30.99% ]

EBS - Operating Cash Flow Margin, Last 5 years

-26.04%

Minimum

Jun 30, 2023

34.46%

Maximum

Dec 31, 2020

8.2%

Average

13.85%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%